Synaptic Systems

Synaptic Systems was founded by scientists and started business in 1997 with a handful of licensed antibodies against synaptic proteins already well known in the scientific community for their excellent quality. In 2002 Synaptic Systems set up its own research laboratory for product refinement and the development of new antibodies.
All products are exclusively available under the Synaptic Systems brand. They are produced and tested in our own facilities to guarantee best quality and reliability. We try to develop as few polyclonal antibodies as possible and to convert existing polyclonal antibodies into recombinant antibodies. In this way, we try to minimize the number of polyclonal antibodies in our portfolio and thus increase animal welfare. Currently, >25% of our antibodies are monoclonal antibodies and another >10% are recombinantly produced monoclonal antibodies, number steadily increasing.
Synaptic Systems offers one of the largest collections of antibodies against synaptic proteins and a growing panel of antibodies for cell biology. In 2017, Synaptic Systems introduced the HistoSure product line. HistoSure antibodies have been specifically developed for use in immunology and cancer research.